EUVIMEDEUVIMED entdecken
Crossref

Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging Before Radical Prostatectomy

Reha-Baris Incesu, Felix Preisser, Raisa S Pompe, Florian Nohe, Philipp Mandel, Tobias Maurer, Markus Graefen, Derya Tilki

European Urology Focus · 2025-07 · 11 (4) · 582-587

DOI: 10.1016/j.euf.2025.01.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Urology Focus, 2025-07. Verfasst von Reha-Baris Incesu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Martini-Klinik Prostate Cancer Center University Hospital Hamburg-Eppendorf Hamburg Germany. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Prostatic Neoplasms, Prostatectomy, Lymph Nodes. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND OBJECTIVE: Prostate-specific-membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) is more accurate than conventional imaging for lymph node (LN) staging in prostate cancer. However, it has limitations in detecting micrometastatic lymph node invasion (LNI). Our aim was to evaluate the accuracy of PSMA PET/CT for overall and size-dependent LNI detection in contemporary patients undergoing radical prostatectomy (RP) and pelvic lymph node dissection (PLND). METHODS: Within a high-volume center database, we identified 873 patients who underwent PSMA PET/CT for primary staging before RP and PLND between 2016 and 2021. Data for lymph node status on imaging and histology results were analyzed. KEY FINDINGS AND LIMITATIONS: Of 873 patients, 25% (n = 220) had LNI. Median prostate-specific antigen was 8.3 ng/ml (interquartile range 4.3-14.3). The majority of patients had high-risk (53%) or intermediate-risk disease (45%). In the overall cohort, the per-patient sensitivity, specificity, positive predictive value, negative predictive value (NPV), and accuracy calculated for LNI detection via PSMA PET/CT were 45.5%, 92.6%, 67.6%, 83.4%, and 80.8%, respectively. The median metastatic LN size in the group of 120 patients with false-negative PET/CT results was 2.5 mm. For metastatic LNs ≥5 mm, the sensitivity and NPV increased to 68.8% (+23.3%) and 95.4% (+12.0%), respectively. The main limitation is the lack of central review of PSMA PET/CT scans. CONCLUSIONS AND CLINICAL IMPLICATIONS: PSMA PET/CT is accurate in the staging of pelvic LNs before RP, especially for detection of metastases in LNs with a diameter ≥5 mm.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyProstatic NeoplasmsProstatectomyLymph NodesGlutamate Carboxypeptidase IIHumansMaleNeoplasm StagingMiddle AgedAgedLymphatic MetastasisLymph Node ExcisionAntigens, SurfaceRetrospective Studies

Stichwörter der Autor:innen

Lymph nodeLymph node invasionMetastasesProstate cancerProstate-specific membrane antigenStaging

Substanzen

Glutamate Carboxypeptidase IIFOLH1 protein, humanAntigens, Surface

Autor:innen und Institutionen

  • Martini-Klinik Prostate Cancer Center University Hospital Hamburg-Eppendorf Hamburg Germany.
  • Martini-Klinik Prostate Cancer Center University Hospital Hamburg-Eppendorf Hamburg Germany; Department of Urology University Hospital Hamburg-Eppendorf Hamburg Germany; Department of Urology Koc University Hospital Ist…

Zitieren

APA

Incesu, R. B., Preisser, F., Pompe, R. S., Nohe, F., Mandel, P., Maurer, T., Graefen, M., & Tilki, D. (2025). Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging Before Radical Prostatectomy. European Urology Focus, 11(4), 582-587. https://doi.org/10.1016/j.euf.2025.01.015

Vancouver

Incesu RB, Preisser F, Pompe RS, Nohe F, Mandel P, Maurer T, et al. Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging Before Radical Prostatectomy. European Urology Focus. 2025;11(4):582-587. doi:10.1016/j.euf.2025.01.015

BibTeX
@article{Incesu2025,
  author = {Incesu, Reha-Baris and Preisser, Felix and Pompe, Raisa S and Nohe, Florian and Mandel, Philipp and Maurer, Tobias and Graefen, Markus and Tilki, Derya},
  title = {Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging Before Radical Prostatectomy},
  journal = {European Urology Focus},
  year = {2025},
  volume = {11},
  number = {4},
  pages = {582--587},
  doi = {10.1016/j.euf.2025.01.015}
}
Kostenlos starten →